Exploratory Study to Assess the Safety and Efficacy of CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

Study Summary

This is an open-label, single arm study to evaluate the safety and tolerability of treatment with CT0594CP CAR-T Cells in patients with relapsed and/or refractory multiple myeloma or Plasma Cell Leukemia

Interventions

Study Locations

Facility	City	State	Country
First Affiliated Hospital, Soochow University	Suzhou	Jiangsu	China

Official Trial Information

View on ClinicalTrials.gov